These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3584400)

  • 1. 15N tracer techniques for the differential diagnosis of dwarfism and prediction of growth hormone action in children.
    Richter I; Heine W; Plath C; Mix M; Wutzke KD; Töwe J
    J Clin Endocrinol Metab; 1987 Jul; 65(1):74-7. PubMed ID: 3584400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
    Kohno H; Murakami Y; Kodaira T
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
    Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K; Goh M; Sato S; Shimizu Y; Sasaki A; Aida M; Yoshinaga K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of nitrogen and whole-body protein metabolism in growth hormone-deficient children by recombinant human growth hormone: relationship to growth.
    Zeisel HJ; Willgerodt H; Richter I; Keller E; Mix M; Vilser C; Amendt P; Hinkel GK; Stach B; Jung K
    Horm Res; 1992; 37 Suppl 2():14-21. PubMed ID: 1490663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-hour spontaneous nocturnal growth hormone secretion in growth retarded patients.
    Spadoni GL; Cianfarani S; Bernardini S; Vaccaro F; Galasso C; Manca Bitti ML; Costa F; Boscherini B
    Clin Pediatr (Phila); 1988 Oct; 27(10):473-8. PubMed ID: 3168384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and urinary GH following a standardized exercise protocol to assess GH production in short children.
    Sartorio A; Palmieri E; Vangeli V; Conte G; Narici M; Faglia G
    J Endocrinol Invest; 2001; 24(7):515-21. PubMed ID: 11508786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
    de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
    J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth hormone secretion following administration of growth hormone releasing hormone in constitutional short stature and idiopathic growth hormone deficiency].
    Butenandt O; Kiess W
    Monatsschr Kinderheilkd; 1987 Feb; 135(2):114-5. PubMed ID: 3106789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.
    Schriock EA; Lustig RH; Rosenthal SM; Kaplan SL; Grumbach MM
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1043-9. PubMed ID: 6427257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.
    Spagnoli A; Gargosky SE; Spadoni GL; MacGillivray M; Oh Y; Boscherini B; Rosenfeld RG
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3668-76. PubMed ID: 8530618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I (IGF-I) screening for the diagnosis of growth hormone (GH) deficiency.
    Sriphrapradang A; Mahachoklertwattana P; Choubtum L; Preeyasombat C
    J Med Assoc Thai; 1997 Jan; 80(1):51-5. PubMed ID: 9078817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.